§ 13F · FUND PROFILE
Aisling Capital Management LP.
AUM · $472M (13F)Positions · 14Turnover · n/a · Q2Filed · Aug 13, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$2M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | BBIO | BRIDGEBIO PHARMA INC | 4.59M | $342M | 72.5% | −10% |
| 2 | GLUE | MONTE ROSA THERAPEUTICS INC | 1.56M | $38M | 8.0% | ±0% |
| 3 | SNDX | SYNDAX PHARMACEUTICALS INC | 1.32M | $29M | 6.1% | ±0% |
| 4 | CMPS | COMPASS PATHWAYS PLC | 1.43M | $20M | 4.3% | ±0% |
| 5 | BCAX | BICARA THERAPEUTICS INC | 569K | $17M | 3.6% | ±0% |
| 6 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 1.02M | $8M | 1.6% | ±0% |
| 7 | SRRK | SCHOLAR ROCK HLDG CORP | 77K | $4M | 0.9% | ±0% |
| 8 | URGN | UROGEN PHARMA LTD | 108K | $4M | 0.8% | ±0% |
| 9 | BMEA | BIOMEA FUSION INC | 2.05M | $3M | 0.6% | ±0% |
| 10 | ACRS | ACLARIS THERAPEUTICS INC | 434K | $2M | 0.5% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE AISLING SIGNAL
AC read
Aisling Capital Management LP is a Other fund managing $472 million in assets. The fund runs a focused portfolio of just 14 positions.
Read the full dossier →